Bernie Simone

Bernie Simone has extensive experience in the healthcare industry, spanning over 30 years. Their work experience includes serving as the Chief Operating Officer at Harm Reduction Therapeutics and Vice President of Client Strategy and Rx-to-OTC Switch at Pinney Associates, Inc. Bernie has also held leadership roles at major pharmaceutical companies such as Sanofi CHC, Chattem, a Division of Sanofi, Bayer HealthCare, and Bristol Myers Squibb Consumer Products. Their expertise includes managing Rx-to-OTC switches, global marketing, growth and commercialization, and new business development. Simone's notable achievements include leading the Cialis Rx-to-OTC switch team and creating strategic plans for the Aspirin cancer research initiative while serving as Global Head of Growth and Commercialization at Bayer HealthCare.

Bernie Simone has a Bachelor of Science degree in Industrial Engineering from Rutgers University. Bernie also holds a Master of Science degree in Management from Stevens Institute of Technology. However, no information about the start and end years for either degree program is provided.